drugset / Trial / NCT02863861

Sedation for Upper Gastrointestinal Endoscopy in Pediatric Patients

NCT02863861 ↗

Phase 4 Completed 120 enrolled Ain Shams University
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to compere between Propofol-Ketamine combination and Dexmedetomidine-Ketamine combination for sedation in upper gastrointestinal endoscopy in paediatric patients.

Timeline

Start
2016-09
Primary completion
2016-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Propofol Small molecule 1 mg/kg Intravenous
Background Ketamine Small molecule 1 mg/kg Intravenous

Indications

No indication recorded.